Download
1 / 1
10 likes | 91 Views
Supplementary Figure 1. In-stent LL, mean (SD), mm. Baseline characteristics. No. of patients. Difference (95% CI). Control. Celecoxib. P int. Sex Male Female Age ≥65 years <65 years Diabetes Yes No LAD Yes No Type C lesion Yes No DES
E N D
Supplementary Figure 1. In-stent LL, mean (SD), mm Baseline characteristics No. of patients Difference (95% CI) Control Celecoxib P int Sex Male Female Age ≥65 years <65 years Diabetes Yes No LAD Yes No Type C lesion Yes No DES Paclitaxel Zotarolimus Cilostazol Yes No All 531 259 426 364 223 567 417 373 377 413 468 322 315 475 790 0.66 (0.56) 0.57 (0.51) 0.60 (0.50) 0.52 (0.40) 0.64 (0.55) 0.52 (0.45) 0.64 (0.54) 0.59 (0.50) 0.64 (0.57) 0.61 (0.50) 0.64 (0.53) 0.53 (0.46) 0.64 (0.52) 0.57 (0.48) 0.64 (0.57) 0.54 (0.46) 0.66 (0.56) 0.60 (0.49) 0.62 (0.53) 0.51 (0.46) 0.56 (0.50) 0.49 (0.45) 0.76 (0.58) 0.65 (0.50) 0.58 (0.53) 0.50 (0.41) 0.68 (0.55) 0.59 (0.50) 0.64 (0.54) 0.55 (0.47) -0.09 (-0.18 to 0.00) -0.07 (-0.19 to 0.04) -0.12 (-0.21 to -0.02) -0.02 (-0.15 to 0.06) -0.02 (-0.17 to 0.12) -0.11 (-0.19 to -0.03) -0.07 (-0.17 to 0.03) -0.10 (-0.20 to 0.01) -0.06 (-0.16 to -0.05) -0.11 (-0.21 to -0.02) -0.07 (-0.15 to 0.02) -0.11 (-0.23 to 0.01) -0.09 (-0.19 to 0.02) -0.09 (-0.18 to 0.01) -0.08 (-0.16 to -0.01) 0.83 0.35 0.28 0.70 0.46 0.58 1.00 -0.24 -0.12 0 0.12 Celecoxib better Control better
